---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-133322"
form_type: "8-K"
ticker: "SLNO"
cik: "0001484565"
company_name: "SOLENO THERAPEUTICS INC"
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T17:37:28.065398+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Soleno Therapeutics prices $138M public offering of 3M shares at $46/share

## Summary
- Public offering of 3,000,000 shares at $46.00 per share for gross proceeds of ~$138M.
- Net proceeds estimated at ~$129.3M after underwriting discounts and expenses.
- Underwriters granted 30-day option to purchase up to 450,000 additional shares.
- Proceeds to fund R&D for DCCR (Prader-Willi Syndrome) and general corporate purposes.
- Offering expected to close on or about May 7, 2024.

## SEC filing metadata
- accession: 0001193125-24-133322
- form_type: 8-K
- ticker: SLNO
- cik: 0001484565
- company_name: SOLENO THERAPEUTICS INC
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484565/000119312524133322/0001193125-24-133322-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484565/000119312524133322/d808535d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-133322
- JSON: https://secwatch.observer/filing/0001193125-24-133322.json
- Plain text: https://secwatch.observer/filing/0001193125-24-133322.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.